Pinzani M, Rosselli M, Zuckermann M (2011) Liver cirrhosis. Best Pract Res Clin Gastroenterol 25(2):281–290. https://doi.org/10.1016/j.bpg.2011.02.009

Article  PubMed  CAS  Google Scholar 

Ndakotsu A, Vivekanandan G (2022) The role of thiazolidinediones in the amelioration of nonalcoholic fatty liver disease: a systematic review. Cureus 14(5):e25380. https://doi.org/10.7759/cureus.25380

Article  PubMed  PubMed Central  Google Scholar 

Ismaiel A, Dumitraşcu DL (2019) Cardiovascular risk in fatty liver disease: the liver-heart axis—literature review. Front Med (Lausanne) 6:202. https://doi.org/10.3389/fmed.2019.00202

Article  PubMed  Google Scholar 

Luo Y, Yin S, Chen Q, Liu J, Chong Y, Zhong J (2023) Comparison of the 2005 Montreal Criteria and the 2019 Cirrhotic Cardiomyopathy Consortium Criteria for the Diagnosis of Cirrhotic Cardiomyopathy. Am J Cardiol 208:180–189. https://doi.org/10.1016/j.amjcard.2023.09.069

Article  PubMed  Google Scholar 

Izzy M, VanWagner LB, Lin G et al (2020) Redefining cirrhotic cardiomyopathy for the modern era. Hepatology 71(1):334–345. https://doi.org/10.1002/hep.30875

Article  PubMed  Google Scholar 

Wiese S, Voiosu A, Hove JD et al (2020) Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy. Aliment Pharmacol Ther 52(2):340–350. https://doi.org/10.1111/apt.15812

Article  PubMed  CAS  Google Scholar 

Ruiz-del-Árbol L, Serradilla R (2015) Cirrhotic cardiomyopathy. World J Gastroenterol 21(41):11502–11521. https://doi.org/10.3748/wjg.v21.i41.11502

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zardi EM, Abbate A, Zardi DM et al (2010) Cirrhotic cardiomyopathy. J Am Coll Cardiol 56(7):539–549. https://doi.org/10.1016/j.jacc.2009.12.075

Article  PubMed  CAS  Google Scholar 

Spann A, Coe C, Ajayi T et al (2022) Cirrhotic cardiomyopathy: appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes. Liver Transpl 28(8):1321–1331. https://doi.org/10.1002/lt.26460

Article  PubMed  PubMed Central  Google Scholar 

Biancofiore G, Mandell MS, Rocca GD (2010) Perioperative considerations in patients with cirrhotic cardiomyopathy. Curr Opin Anaesthesiol 23(2):128–132. https://doi.org/10.1097/ACO.0b013e328337260a

Article  PubMed  Google Scholar 

Merli M, Valeriano V, Funaro S et al (2002) Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 97(1):142–148. https://doi.org/10.1111/j.1572-0241.2002.05438.x

Article  PubMed  Google Scholar 

Gassanov N, Caglayan E, Semmo N, Massenkeil G, Er F (2014) Cirrhotic cardiomyopathy: a cardiologist’s perspective. World J Gastroenterol 20(42):15492–15498. https://doi.org/10.3748/wjg.v20.i42.15492

Article  PubMed  PubMed Central  Google Scholar 

Ali SA, Arman HE, Shamseddeen H et al (2023) Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant. J Cardiol 82(2):113–121. https://doi.org/10.1016/j.jjcc.2023.04.007

Article  PubMed  Google Scholar 

Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F (2015) Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol 28(1):31–40

PubMed  PubMed Central  Google Scholar 

Bolognesi M, Di Pascoli M, Verardo A, Gatta A (2014) Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol 20(10):2555–2563. https://doi.org/10.3748/wjg.v20.i10.2555

Article  PubMed  PubMed Central  CAS  Google Scholar 

Felli E, Nulan Y, Selicean S, Wang C, Gracia-Sancho J, Bosch J (2023) Emerging therapeutic targets for portal hypertension. Curr Hepatol Rep. 22(1):51–66. https://doi.org/10.1007/s11901-023-00598-4

Article  PubMed  PubMed Central  Google Scholar 

Møller S, Henriksen JH (2008) Cardiovascular complications of cirrhosis. Gut 57(2):268–278. https://doi.org/10.1136/gut.2006.112177

Article  PubMed  CAS  Google Scholar 

Dourakis SP, Geladari E, Geladari C, Vallianou N (2021) Cirrhotic cardiomyopathy: the interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased? Curr Cardiol Rev. 17(1):78–84. https://doi.org/10.2174/1573403X15666190509084519

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wong F, Liu P, Lilly L, Bomzon A, Blendis L (1999) Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci (Lond) 97(3):259–267

Article  PubMed  CAS  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314. https://doi.org/10.1016/j.echo.2016.01.011

Article  PubMed  Google Scholar 

Baik SK, Fouad TR, Lee SS (2007) Cirrhotic cardiomyopathy. Orphanet J Rare Dis 2:15. Published 2007 Mar 27. https://doi.org/10.1186/1750-1172-2-15

Stundiene I, Sarnelyte J, Norkute A et al (2019) Liver cirrhosis and left ventricle diastolic dysfunction: systematic review. World J Gastroenterol 25(32):4779–4795. https://doi.org/10.3748/wjg.v25.i32.4779

Article  PubMed  PubMed Central  Google Scholar 

Bernardi M, Maggioli C, Dibra V, Zaccherini G (2012) QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol 6(1):57–66. https://doi.org/10.1586/egh.11.86

Article  PubMed  Google Scholar 

Ytting H, Henriksen JH, Fuglsang S, Bendtsen F, Møller S (2005) Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J Hepatol 43(4):637–644. https://doi.org/10.1016/j.jhep.2005.04.015

Article  PubMed  Google Scholar 

Papadopoulos VP, Mimidis K (2023) Corrected QT interval in cirrhosis: a systematic review and meta-analysis. World J Hepatol 15(9):1060–1083. https://doi.org/10.4254/wjh.v15.i9.1060

Article  PubMed  PubMed Central  Google Scholar 

Oyelade T, Canciani G, Carbone G, Alqahtani JS, Moore K, Mani AR (2021) Heart rate variability in patients with cirrhosis: a systematic review and meta-analysis. Physiol Meas 42(5):https://doi.org/10.1088/1361-6579/abf888. Published 2021 Jun 17. https://doi.org/10.1088/1361-6579/abf888

Lunseth JH, Olmstead EG, Abboud F (1958) A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med 102(3):405–413. https://doi.org/10.1001/archinte.1958.00030010405009

Article  PubMed  CAS  Google Scholar 

Nakamori S, Dohi K, Ishida M et al (2018) Native T1 Mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11(1):48–59. https://doi.org/10.1016/j.jcmg.2017.04.006

Article  PubMed  Google Scholar 

Lin L, Li X, Feng J et al (2018) The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. J Cardiovasc Magn Reson 20(1):2. Published 2018 Jan 3. https://doi.org/10.1186/s12968-017-0419-6

Kim HM, Kim HK, Lee JH et al (2020) Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson 22(1):25. Published 2020 Apr 23. https://doi.org/10.1186/s12968-020-00622-2

Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L (2001) The cardiac response to exercise in cirrhosis. Gut 49(2):268–275. https://doi.org/10.1136/gut.49.2.268

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu H, Naser JA, Lin G, Lee SS (2023) Cardiomyopathy in cirrhosis: from pathophysiology to clinical care. JHEP Rep 6(1):100911. Published 2023 Sep 23. https://doi.org/10.1016/j.jhepr.2023.100911

Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM (2020) Markers of myocardial stress, myocardial injury, and subclinical inflammation and the risk of sudden death. Circulation. 142(12):1148–1158. https://doi.org/10.1161/CIRCULATIONAHA.120.046947